The Global Antitrust Economics Conference
Rainer Schwabe and Anand Krishnamurthy will join competition experts to discuss the role of financial services and life sciences in antitrust.
Value Drug Company v. Takeda Pharmaceuticals U.S.A. Inc. et al.
Laurence Baker testified during a rare antitrust trial centering on the allegation that a brand manufacturer conspired with three generics to allocate the market for gout medication colchicine.
In re Novartis and Par Antitrust Litigation
Novartis reached settlements with plaintiffs in this reverse payment matter.
Amgen Inc.’s Acquisition of Horizon Therapeutics plc
The FTC approves Amgen’s $28B purchase of Horizon.
The Economics of New Product Launches and Access to Pharmaceutical Products in the EU
The authors provide an economic perspective on the European Commission’s proposed reform of the EU’s pharmaceutical legislation.
In re HIV Antitrust Litigation
The jury found in favor of the defense concluding, consistent with Dr. Saravia’s testimony, that the settlement contained no payment for delay.
The Inflation Reduction Act Could Have Unintended Consequences
This article analyzes the potential unintended economic impacts of the Inflation Reduction Act on the pharmaceutical industry.
The Inflation Reduction Act’s Effects on the Life Sciences Industry
These experts are at the forefront of research into the IRA’s potential effects on pharmaceuticals.
American Conference Institute: 14th Summit on Biosimilars & Innovator Biologics
Alice Chen of the USC Sol Price School of Public Policy will discuss the impact of the Inflation Reduction Act (IRA) at this annual event.
Expert Network for Women in Healthcare and Life Sciences
This network connects women economists and academics working on healthcare and life sciences topics and offers an opportunity to learn about expert witness work.
How can we help you?
If you are looking for a publication not on our website, contact us.
